DC
Deciphera
DCPH·NASDAQWaltham MAFounded 2003350 employees
Mid CapbiotechPublicOncology
Platform: Kinase Ripretinib
Market Cap
$2.5B
All Drugs
3
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (DCPH)
Loading DCPH stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Rimasacituzumab | DCP-9994 | Phase 2 | 2 | FcRn | CMLMCL | ||
| Niraglumide | DCP-6370 | Preclinical | 1 | AHR | CMLPancreatic Ca | ||
| DCP-2468 | DCP-2468 | Preclinical | 1 | MALT1 | PsoriasisMG |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)